Malaria

A vaccine against a devastating form of malaria common in Asia and South America is one step closer thanks to a long-awaited methodological advance

The mechanism by which malaria parasites accumulate in the brain and other deep tissues of model mice has been identified

The antifolate drug methotrexate is highly potent against the malaria parasite Plasmodium vivax

The versatile chemical synthesis of natural fungal compounds should lead to new candidates for malaria treatments

A ‘whole parasite’ strategy could lead to a vaccine for one of the world’s deadliest diseases

Drugs that selectively target pre-symptomatic, liver-stage malarial infection could ultimately help thwart this deadly disease.